Bay Street News, January 14th, 2019

HINGHAM, Mass., Jan. 14, 2019 (GLOBE NEWSWIRE) — Microbot Medical (NASDAQ: MBOT) announced today that it has validated the operational […]

New target Showed Synergy When Combined With Leading Drug Therapy VANCOUVER, British Columbia, Jan. 14, 2019 (GLOBE NEWSWIRE) — Nash […]

TARRYTOWN, N.Y., Jan. 14, 2019 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc. (NYSE:PBH) today updated its guidance for the third […]

Expects Double-Digit Revenue Growth GREENVILLE, S.C., Jan. 14, 2019 (GLOBE NEWSWIRE) — Delta Apparel, Inc. (NYSE American: DLA), a leading […]

TULSA, Okla., Jan. 14, 2019 (GLOBE NEWSWIRE) — SemGroup® Corporation (NYSE:SEMG) is scheduled to participate in the UBS Midstream, MLP […]

NEW ALBANY, Ohio, Jan. 14, 2019 (GLOBE NEWSWIRE) — Abercrombie & Fitch Co. (NYSE: ANF) today announced that it is […]

LOS ANGELES, Jan. 14, 2019 (GLOBE NEWSWIRE) — Rubicon Project (NYSE: RUBI), the Global Exchange for advertising, will announce its […]

HINGHAM, Mass., Jan. 14, 2019 (GLOBE NEWSWIRE) — Microbot Medical Inc. (NASDAQ: MBOT), received a notification from the European Patent […]

-PDUFA action date now set for April 30, 2019- DUBLIN, Ireland, Jan. 14, 2019 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc […]

SAN DIEGO, Jan. 14, 2019 (GLOBE NEWSWIRE) — Scilex Pharmaceuticals Inc. (SCILEX), a subsidiary of Sorrento Therapeutics, Inc. (NASDAQ: SRNE), […]